These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28577795)

  • 1. FDA Town Hall at CRT 2017: Current status and future endeavors in cardiovascular devices.
    Buchanan KD; Alraies MC; Waksman R
    Cardiovasc Revasc Med; 2017 Jun; 18(4):308-311. PubMed ID: 28577795
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA regulation of cardiovascular devices and opportunities for improvement.
    Dhruva SS; Redberg RF
    J Interv Card Electrophysiol; 2013 Mar; 36(2):99-105. PubMed ID: 23263896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence strength in FDA premarket approval of cardiovascular devices.
    Kong DF; Hasselblad V; Krucoff MW
    JAMA; 2010 Apr; 303(16):1599-600; author reply 1600-1. PubMed ID: 20424248
    [No Abstract]   [Full Text] [Related]  

  • 4. Publication of Clinical Studies Supporting FDA Premarket Approval for High-Risk Cardiovascular Devices Between 2011 and 2013: A Cross-sectional Study.
    Phillips AT; Rathi VK; Ross JS
    JAMA Intern Med; 2016 Apr; 176(4):551-2. PubMed ID: 26902933
    [No Abstract]   [Full Text] [Related]  

  • 5. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA approves first pacemaker system safe for magnetic resonance imaging. Traditional cardiac devices have been at risk of malfunctioning or overheating with MRIs.
    Heart Advis; 2011 Apr; 14(4):1, 11. PubMed ID: 22973585
    [No Abstract]   [Full Text] [Related]  

  • 7. Gender bias in studies for Food and Drug Administration premarket approval of cardiovascular devices.
    Dhruva SS; Bero LA; Redberg RF
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):165-71. PubMed ID: 21364127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical-device safety and the FDA.
    Schultz DG
    N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program.
    Jones LC; Dhruva SS; Redberg RF
    JAMA Intern Med; 2018 Oct; 178(10):1418-1420. PubMed ID: 30178044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opening the FDA black box.
    Goodman SN; Redberg RF
    JAMA; 2014 Jan 22-29; 311(4):361-3. PubMed ID: 24449313
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of evidence behind FDA approvals varies widely.
    McCarthy M
    BMJ; 2014 Jan; 348():g1075. PubMed ID: 24470635
    [No Abstract]   [Full Text] [Related]  

  • 13. Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval.
    Chen CE; Dhruva SS; Redberg RF
    JAMA; 2012 Nov; 308(17):1740-2. PubMed ID: 23117769
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing new ICD technology.
    Shein MJ; Schultz DG
    N Engl J Med; 2008 Dec; 359(24):2610. PubMed ID: 19073982
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation Without Representation: Cardiac Device Patient Knowledge and Attitudes About the FDA Regulatory Process.
    Zeitler EP; Al-Khatib SM; Yapejian R; Tripp CC; Sears SF
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008561. PubMed ID: 32628518
    [No Abstract]   [Full Text] [Related]  

  • 16. So We Have Bioresorbable Scaffolds: Now What?
    King SB
    JACC Cardiovasc Interv; 2016 May; 9(10):1087-8. PubMed ID: 27198690
    [No Abstract]   [Full Text] [Related]  

  • 17. New type of defibrillator.
    FDA Consum; 2002; 36(4):7. PubMed ID: 12184312
    [No Abstract]   [Full Text] [Related]  

  • 18. Advertising of therapies for cardiovascular patients.
    Foster MC
    Clin Cardiol; 1997 May; 20(5):506-7. PubMed ID: 9134288
    [No Abstract]   [Full Text] [Related]  

  • 19. An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillance.
    Laskey W; Awad K; Lum J; Skodacek K; Zimmerman B; Selzman K; Zuckerman B
    Am J Ther; 2012 Jul; 19(4):248-54. PubMed ID: 22668602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning from our mistakes? Testing new ICD technology.
    Hauser RG; Almquist AK
    N Engl J Med; 2008 Dec; 359(24):2517-9. PubMed ID: 19073974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.